Comparison of Preplanning and Intraoperative Planning for I-125 Prostate Brachytherapy
Authors:
Open Access
- 11 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 43 (4) , 383-389
Abstract
To compare two widely used permanent prostate brachytherapy techniques, preplanning and intraoperative planning, based on postimplant dosimetry, toxicity and biochemical outcomes. Between 2003 and 2006, 665 men with localized prostate cancer were treated with permanent interstitial implantation. The first 227 consecutive men were treated with the preplanning technique, followed by 438 men treated with the intraoperative technique. Late toxicity was scored by the Common Terminology Criteria for Adverse Events v.4.0. Biochemical failure was defined as a prostate-specific antigen increase of more than 2 ng/ml above the nadir value excluding a benign bounce. Univariate and multivariate analyses were performed to identify the variables associated with biochemical failure-free survival. Postimplant target coverage was similar in the two groups, with a small difference in risk organ doses. Mean V100 was 96.3 vs. 96.7% (P = 0.205), D90 was 119.6 vs. 119.4% (P = 0.884), urethral D10 was 157.5 vs. 146.1% (P = 0.010), rectal V100 was 0.57 vs. 0.43 cc (P = 0.002) in the preplanning and intraoperative planning groups, respectively. Acute and late Grade 3 genitourinary and gastrointestinal toxicities were P = 0.776). Multivariate analysis revealed Gleason score, biopsy positive rate and V100 to be predictors of biochemical failure-free survival, while the planning technique was not significant. This large-scale analysis of high-quality implants revealed similar postimplant dosimetry, toxicity profiles and biochemical failure-free survival for the preplanning and intraoperative planning methods.Keywords
This publication has 23 references indexed in Scilit:
- Prospective comparison of PSA kinetics following two different prostate cancer brachytherapy planning methods: Preoperative and real-time intraoperative dosimetry planningUrologic Oncology: Seminars and Original Investigations, 2012
- Fifteen-Year Biochemical Relapse-Free Survival, Cause-Specific Survival, and Overall Survival Following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Influence of Pretreatment and Treatment Factors on Intermediate to Long-Term Outcome After Prostate BrachytherapyJournal of Urology, 2011
- Population-based Study of Biochemical and Survival Outcomes After Permanent 125I Brachytherapy for Low- and Intermediate-risk Prostate CancerUrology, 2009
- Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomesBrachytherapy, 2009
- Rectal Morbidity Following I-125 Prostate Brachytherapy in Relation to DosimetryJapanese Journal of Clinical Oncology, 2007
- Acute urinary morbidity following I-125 prostate brachytherapyInternational Journal of Clinical Oncology, 2005
- Technical improvement in permanent seed implantation: a two-stage brachytherapy system. Description and comparison with current techniqueBrachytherapy, 2004
- Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: A dosimetric analysisBrachytherapy, 2004
- Toward a dynamic real-time intraoperative permanent prostate brachytherapy methodologyBrachytherapy, 2003